middle.news
Entropy Neurodynamics Reports 50% Remission in BED Trial and Expands Clinical Program
9:44am on Friday 28th of August, 2026 AEST
•
Healthcare
Read Story
Entropy Neurodynamics Reports 50% Remission in BED Trial and Expands Clinical Program
9:44am on Friday 28th of August, 2026 AEST
Key Points
30% income increase to $2.06 million
Loss after tax narrowed 8.7% to $4.87 million
Phase 2 BED trial shows 50% complete remission in Cohort 1
72-patient multi-indication basket study approved
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Entropy Neurodynamics (ASX:ENP)
OPEN ARTICLE